Department of Veterans Affairs Electrotherapeutic Modalities - Industry Days

The Department of Veteran Affairs, National Acquisition Office (NAC), Commodities, Services, and Acquisition Services (CSAS) in conjunction with Veteran Health Administration (VHA), Prosthetic Sensory Aid Services (PSAS), is issuing a Request for Information and Sources Sought Announcement for Electrotherapeutic Modalities. The sole purpose of this announcement is to make industry aware that the Department of Veterans Affairs will be conducting Industry Day’s the last week of February 2026. The reason for conducting Industry Day’s is strictly for market research purposes and does not constitute a Request for Quote (RFQ)/Invitation for Bid (IFB)/Request for Proposal (RFP). DISCLAIMER This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. A central tenet of acquisition reform is to significantly improve the quality of market research by conducting a market and industry survey. One of the main benefits of solid market research is to materially improve the government’s understanding of the current state of the marketplace, including commercial/government best practices, industry capabilities, innovative delivery approaches, commercial market service levels, and performance strategies and measures. The North American Industry Classification System (NAICS) category and Product Service Code (PSC) category for this requirement are as follows. NAICS: 334510 – Electromedical and Electrotherapeutic Devices PSC: 6515 - Medical and Surgical Instruments, Equipment, And Supplies The upcoming recompete for the Department of Veteran Affairs Transcutaneous Electrical Nerve Stimulation (TENS), and additional CLINS which will steer the program toward an all-encompassing Electrotherapeutic Modalities emphasis; requires intricate consideration on market research relating to market/industry infrastructure practices and product availability. We intend to address the Buy American Act, Trade Agreement Act, Clin Categories for at home devices, FDA cleared indications of use, mechanisms of delivery, device accessories, procurement process, distribution model, government sales, socioeconomic status of distributors and more. We are also interested in identifying performance criteria that differentiate between and among high-quality products in this field. We believe this information will dramatically improve the quality of the forthcoming acquisition, including the solicitation and resulting contract. Each company will be allotted forty-five minutes to demonstrate, inform and discuss their companies product or products. Please RSVP via email with Maurice Walker at [email protected] and Jonathan Saiz at [email protected] for this industry day NLT 5PM MST, 02/10/2026. In your email, please provide the following information; company name, names and titles of all who plan to attend, socioeconomic status and whether your company is a manufacturer or authorized distributor. Date: 02/23/2026 – 02/27/2026 (The 23rd and 27th are designated travel days) Time: 09:00am – 04:30pm MST (Tentative based on number of participants) Location: Denver Logistics Center, 555 Corporate Circle, Golden, CO. 80401. Please note that questions for industry participants and the current minimum technical requirements are attached to this RFI post toward the bottom of the posting. Please have the answers to these questions available in a document provided prior to your session via the POCs above, or readily available at your session. Directions from DIA airport to the Denver Logistics Center, and lodging and dining recommendations are also attached to this RFI. Responding parties should take additional precautionary measures to prevent proprietary information from disclosure by marking the documentation being submitted with labeling sensitivities such as confidential and proprietary. Information provided in response to this RFI and future RFI’s that is marked as proprietary will be handled accordingly.